Alzheimer Disease Test

What Does an Alzheimer Disease Test Measure?

The Alzheimer Disease Test helps your doctor assess protein changes in CSF that are linked with Alzheimer’s disease:

• Total Tau: Helps assess nerve cell injury or degeneration in the brain.
• B Amyloid (1-42): Helps assess amyloid-related changes that may be associated with Alzheimer’s disease.
• B Amyloid (1-40): Helps support interpretation of amyloid levels and improves assessment when used with B Amyloid (1-42).
• B Amyloid ratio (1-42/1-40): Helps assess amyloid imbalance more reliably than a single amyloid value in many clinical settings.
• Cognitive Decline Evaluation: Supports investigation when you have memory loss, confusion or changes in thinking ability.
• Differential Diagnosis Support: Helps your doctor distinguish Alzheimer’s disease patterns from some other causes of cognitive decline.

Alzheimer Disease Test: Who Needs It and Why It’s Done

What Symptoms May Call for an Alzheimer Disease Test?

Doctors may recommend this test if you have symptoms that suggest cognitive decline:

• Repeated memory loss that affects daily activities
• Difficulty remembering recent conversations or events
• Confusion with time, place or familiar routines
• Trouble finding words or following conversations
• Difficulty planning, organising or solving everyday problems
• Behaviour, mood or personality changes without a clear cause
• Gradual decline in work, social or personal functioning

Who Should Get an Alzheimer Disease Test?

This test may be useful for people who need further evaluation for possible Alzheimer’s disease:

• People with persistent memory problems or cognitive decline
• People advised by a neurologist or specialist for CSF biomarker assessment
• People with mild cognitive impairment where Alzheimer’s disease is being considered
• People whose symptoms need differentiation from other neurodegenerative conditions
• People being evaluated for early intervention strategies
• People being assessed for clinical trial eligibility or specialised treatment planning

Why is an Alzheimer Disease Test Done?

The Alzheimer Disease Test is done to assess CSF amyloid and tau biomarkers that may be associated with Alzheimer’s disease. It helps your doctor make a more informed clinical assessment when memory loss or cognitive decline needs further investigation.

Importance of Alzheimer Disease Test

The Alzheimer Disease Test is important because Alzheimer’s disease can be difficult to assess using symptoms alone, especially in the early stages. CSF biomarkers provide additional biological information that may help your doctor understand whether Alzheimer-related changes are likely to be present.

The test can support earlier evaluation, guide further investigations and help distinguish Alzheimer’s disease from some other causes of dementia or cognitive impairment. Since abnormal biomarker results can occur in complex clinical situations, the report should always be reviewed by a specialist along with your medical history, neurological examination, cognitive testing and imaging results.

Alzheimer Disease Test Booking & Reports - Metropolis Healthcare

How to Book the Alzheimer Disease Test and Get Your Reports?

1. Specialist-Guided Booking
   Booking should be done as advised by your doctor or specialist. Select the Alzheimer Disease Test through the Metropolis Healthcare App or website, or follow the booking guidance provided by the lab team.
2. Clinical History Review
   Clinical history is required for this test. Share your symptoms, neurological history, medicines, previous reports and doctor’s prescription before sample processing.
3. CSF Sample Collection
   The CSF sample must be collected by a qualified clinician through a lumbar puncture or another medically appropriate method. This is not a routine home collection sample.
4. Accurate Laboratory Testing
   Your CSF sample is processed using enzyme immunoassay at the laboratory to measure the listed Alzheimer-related biomarkers.
5. Quick & Easy Reports
   Receive your test reports via email, WhatsApp, or by downloading them directly from the Metropolis Healthcare website or app.

Is Home Sample Collection for Alzheimer Disease Test Available Near You?

No. Home sample collection is not available for the Alzheimer Disease Test. This test requires a CSF sample, which must be collected by a qualified clinician in an appropriate medical setting. The sample must be placed in a leak proof container, and correct handling is important for reliable testing.

In how much time will I get Alzheimer Disease Test report?

Reports are usually available on the same day at 9:00 PM once the sample reaches the lab as per the test schedule.

Note: Reporting time may vary based on your location.

Where can I see or get Alzheimer Disease Test results?

Test results from Metropolis Healthcare can be accessed through multiple convenient channels. You can log in to the Metropolis website using your credentials or use the Metropolis Healthcare App to view and download your reports. Additionally, test reports are sent via email or WhatsApp and you also have the option to collect a physical copy directly from the lab.

Interpreting Alzheimer Disease Test Results

What Your Alzheimer Disease Test Results May Indicate?

Your Alzheimer Disease Test result helps your doctor assess whether your CSF biomarker pattern is suggestive of Alzheimer-related changes. The report should not be interpreted alone, as symptoms, cognitive testing and imaging findings are also important.

Understanding Abnormal Alzheimer Disease Test Results by Parameter

How Should You Prepare for an Alzheimer Disease Test?

The Alzheimer Disease Test needs careful procedural preparation because it uses a CSF sample:

• Follow your doctor’s advice: CSF collection must be planned and performed by a qualified clinician.
• Share your clinical history: Inform your doctor about memory symptoms, neurological problems, previous scans and past test reports.
• Discuss medicines: Tell your doctor if you take blood thinners, aspirin, antiplatelet medicines or any medicine that affects bleeding.
• Mention medical conditions: Inform your doctor if you have a bleeding disorder, infection, raised intracranial pressure or recent neurological illness.
• Ask about fasting: Fasting is not routinely required for the lab test, but your doctor may give procedure-specific instructions.
• Carry documents: Bring your doctor’s prescription, clinical notes and any previous neurological or imaging reports.
• Avoid self-scheduling CSF collection: Do not attempt to arrange the sample without specialist guidance.

How Is an Alzheimer Disease Test Done? (Step-by-Step Procedure)

The Alzheimer Disease Test follows a specialised CSF collection and laboratory testing process:

• Clinical Review: Your doctor reviews your symptoms, medical history and reason for CSF biomarker testing.
• Procedure Preparation: You are positioned safely for CSF collection, usually under medical supervision.
• Site Cleaning: The lower back area is cleaned with an antiseptic solution before the procedure.
• CSF Collection: A qualified clinician collects CSF using a lumbar puncture or another medically appropriate method.
• Sample Transfer: About 2 ml to 3 ml of CSF is placed in a leak proof container. A conical tube is recommended to prevent leakage.
• Completion: The collection site is dressed, and you may be observed as advised by your doctor.
• Processing: Your CSF sample is sent to the laboratory for enzyme immunoassay testing.
• Reporting: Your report is issued with results for Total Tau, B Amyloid (1-42), B Amyloid (1-40) and B Amyloid ratio (1-42/1-40).

Conditions That May Affect Alzheimer Disease Test Accuracy

Several factors can influence CSF biomarker testing and interpretation:

• Incomplete clinical history: Missing information about your symptoms, medicines or neurological history may affect interpretation.
• Incorrect sample handling: The CSF sample must be collected and transported in the correct leak proof container.
• Insufficient sample quantity: A low sample volume may not be enough for accurate testing.
• Blood contamination: Blood mixed with CSF during collection can affect some laboratory measurements.
• Wrong storage condition: This test requires correct frozen sample handling for stability.
• Other neurological conditions: Some infections, inflammation, stroke, trauma or other neurodegenerative diseases can affect CSF protein markers.
• Clinical mismatch: If your symptoms and biomarker pattern do not match, your doctor may advise further testing or specialist review.

Diseases That A Alzheimer Disease Test Can Help Detect

The Alzheimer Disease Test can help your doctor assess conditions linked with cognitive decline:

• Alzheimer’s Disease: Helps assess CSF biomarker patterns associated with Alzheimer’s disease.
• Mild Cognitive Impairment Due to Suspected Alzheimer’s Disease: Supports evaluation when early memory changes may be related to Alzheimer’s disease.
• Neurodegenerative Dementia: Helps in the broader evaluation of dementia-like symptoms.
• Non-Alzheimer Cognitive Disorders: May support differentiation from other causes when interpreted with clinical findings.
• Progressive Memory Disorders: Helps guide further assessment when memory loss is worsening over time.

Alzheimer Disease Test Price in Different Cities

The cost of a Alzheimer Disease Test may vary depending on your location. Here's a table showing the approximate price range for the Alzheimer Disease Test at Metropolis Healthcare in major Indian cities:

The Alzheimer Disease Test cost may vary depending on the city and the specific tests included in the panel. However, Metropolis Healthcare offers competitive Alzheimer Disease Test prices across major cities in India.

References

1. Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535-562. PMID:29653606.
2. Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15(7):673-684. PMID:27068280.
3. Blennow K, Zetterberg H. Biomarkers for Alzheimer's disease: current status and prospects for the future. J Intern Med. 2018;284(6):643-663. PMID:30051512.
4. Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease. Alzheimers Res Ther. 2019;11(1):34. PMID:31010420.
5. Spies PE, Slats D, Sjögren JM, Kremer BP, Verhey FR, Rikkert MG, et al. The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia. Curr Alzheimer Res. 2010;7(5):470-476. PMID:20043812.
6. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Cerebrospinal fluid tau/beta-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol. 2007;64(3):343-349. PMID:17210801.